Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2008
In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureusBrian T Tsuji, Jenny C Yang, Alan Forrest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogensSujata M Bhavnani, Jeffrey P Hammel, Alan Forrest, et al.
Pharmacotherapy|July 30, 2003
Coadministration of milk thistle and indinavir in healthy subjectsRobert DiCenzo, Mark Shelton, Kelly Jordan, et al.
The Journal of Antibiotics|June 9, 2016
Impact of Staphylococcus aureus accessory gene regulator (agr) system on linezolid efficacy by profiling pharmacodynamics and RNAIII expressionRachel L Soon, Justin R Lenhard, Irene Reilly, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of ResistanceSoon-Ee Cheah, Jian Li, Brian T Tsuji, et al.
Journal of Clinical Microbiology|June 9, 2004
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaGeorge Sakoulas, Pamela A Moise-Broder, Jerome Schentag, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection ModelOlanrewaju O Okusanya, Alan Forrest, Sujata M Bhavnani, et al.
Journal of Clinical Pharmacology|January 29, 2008
Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic eventsFrancis M Gengo, Michelle Rainka, Matthew Robson, et al.
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|January 25, 2003
Population pharmacokinetics of linezolid in patients treated in a compassionate-use programAlison K Meagher, Alan Forrest, Craig R Rayner, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2008
In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureusBrian T Tsuji, Jenny C Yang, Alan Forrest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogensSujata M Bhavnani, Jeffrey P Hammel, Alan Forrest, et al.
Pharmacotherapy|July 30, 2003
Coadministration of milk thistle and indinavir in healthy subjectsRobert DiCenzo, Mark Shelton, Kelly Jordan, et al.
The Journal of Antibiotics|June 9, 2016
Impact of Staphylococcus aureus accessory gene regulator (agr) system on linezolid efficacy by profiling pharmacodynamics and RNAIII expressionRachel L Soon, Justin R Lenhard, Irene Reilly, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2013
Pharmacodynamic variability beyond that explained by MICsRachel L Soon, Neang S Ly, Gauri Rao, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of ResistanceSoon-Ee Cheah, Jian Li, Brian T Tsuji, et al.
Journal of Clinical Microbiology|June 9, 2004
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaGeorge Sakoulas, Pamela A Moise-Broder, Jerome Schentag, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin against Streptococcus pneumoniae Using Data from a Neutropenic Murine Lung Infection ModelOlanrewaju O Okusanya, Alan Forrest, Sujata M Bhavnani, et al.
Journal of Clinical Pharmacology|January 29, 2008
Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic eventsFrancis M Gengo, Michelle Rainka, Matthew Robson, et al.
Pageof 18